Novocure
NVCR
#5235
Rank
NZ$2.51 B
Marketcap
Country
NZ$22.47
Share price
-1.63%
Change (1 day)
-31.48%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2025 (TTM): -NZ$0.22 Billion

According to Novocure 's latest financial reports the company's current earnings are NZ$0.64 Billion. In 2024 the company made an earning of -NZ$0.21 Billion, an increase over its 2023 earnings that were of -NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.22 Billion6.76%
2024 -NZ$0.21 Billion-35.88%
2023 -NZ$0.32 Billion139.99%
2022 -NZ$0.14 Billion61.43%
2021 -NZ$82.18 Million-235.99%
2020 NZ$60.42 M630.75%
2019 NZ$8.26 M-115.08%
2018 -NZ$54.84 Million-15.13%
2017 -NZ$64.61 Million-66.9%
2016 -NZ$0.2 Billion10.26%
2015 -NZ$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.21 Million-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.13 Billion-42.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$0.63 B-395.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.22 Billion 0.00% Jersey